A 16-month-old with recurrent otitis media developed a spreading unilateral rash on her hip and thigh during antibiotic treatment. PCR testing confirmed herpes zoster, an uncommon diagnosis in young, vaccinated children.
|Articles|November 4, 2021
The intersection of environment and eczema
Author(s)Linda Stocum, Morgan Ebert, Executive Editor
An interview with Adelaide Hebert, MD, how environmental factors may play a role in flare ups.
Advertisement
Adelaide Hebert, MD, chief of pediatric dermatology at the McGovern Medical School at UTHealth Houston, Texas, highlights how the prevalence of eczema varies and the impact on quality of life. Hebert also highlights how itching can lead to significant disruption in a child’s life, leading to sleep disruption as well as increased discomfort during the hot and humid summer months.
To view the video, click
Advertisement
Related to this article
Upadacitinib showed continued facial and body repigmentation in NSV through week 76, with numerically higher responses when combined with NB-UVB.
Can you guess the diagnosis?
The approval is based on BRAVE-AA-PEDS, in which 42% of adolescents receiving baricitinib 4 mg achieved at least 80% scalp hair coverage at week 36 vs 5% with placebo.
The FDA accepted the dersimelagon NDA with priority review for EPP and XLP; a decision on the oral MC1R agonist is expected by February 2027.
Children with atopic dermatitis have higher ADHD risk, particularly with early, severe disease and sleep disturbance, a review found.
Baseline severity and clinical phenotype may help predict response to systemic therapy in children with alopecia areata.
Can you guess the diagnosis?
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Upadacitinib sustains repigmentation in non-segmental vitiligo through 76 weeks
2
BLA submitted to FDA for Viaskin peanut patch in children aged 4 to 7 years with peanut allergy
3
FDA approves expandable Autus valve for congenital pulmonary valve disease
4
FDA news in pediatrics: September 2026
5